While the study explored how the model outcomes would change if the incidence of dengue were to be variable between 50 and 200% of what was found in the fever study in Laos and found out that still CRP test would outperform both RDTs for dengue and scrub typhus, the study does not report how higher incidence of dengue will impact the median incremental cost and median DALYs averted by using dengue RDTs. Here, CRP is linked to dengue disease.